Accelerating Innovations into CarE (AICE) - Market Access

This program supports Alberta health-tech companies in advancing commercial progression and breaking into new markets.

How Much Funding?

Up to 50%, to a maximum of $300,000 over 24 months

Who Qualifies?

Canada-wide
- Either the SME applicant or the testing site applicant must demonstrate a significant legal and physical presence in Alberta
- Relationship between SME and testing site must not create a conflict of interest

SME Eligibility:
- For profit
- Less than 500 full time employees
- Less than $50M in annual gross revenues
- Legal entity with up to date corporate filings
- Possess a health innovation, ready for clinical/real world testing
Testing site eligibility:
- for-profit, not-for-profit organization or government affiliated entity
- Legal entity
- Possess resources and infrastructure required for supporting the proposed project

Eligible Activities & Expenditures

- Commercialization of novel health technology that has the potential to significantly enhance patient care while simultaneously creating health, social and economic impact for Alberta
- Collaboration between SMEs and real-world testing sites in carrying out implementation projects or clinical trials of innovative health technologies
- Projects must be ready for clinical/real world testing

Project eligibility:
- At least one testable business hypothesis based on evaluation criteria of key purchasing decision-makers or include a testable clinical hypothesis that will support regulatory approval process
- Sound methodology that will test hypotheses and inform any barriers to adoption
- Completed within the 24 month term

Program Deadline

Currently open

Why EVAMAX?

96%+

Approval Rate

75%

Time Saved

33%

Fee Saved